PPARG (Peroxisome Proliferator-Activated Receptor Gamma)
PPARG
Nuclear receptor regulating glucose and lipid metabolism, adipocyte differentiation.
Fonction
Thiazolidinediones (pioglitazone) activate PPARG to improve insulin sensitivity.
Médicaments agissant sur cette cible
| Médicament | Action | Principal |
|---|---|---|
| Methylprednisolone | Agonist | Oui |
| Insulin Glargine | Agonist | Oui |
| Liraglutide | Agonist | Oui |
| Semaglutide | Agonist | Oui |
| Tirzepatide | Agonist | Oui |
| Prednisone | Agonist | Oui |
| Dexamethasone | Agonist | Oui |
| Levothyroxine | Agonist | Oui |
| Spironolactone | Antagonist | Oui |
| Tamoxifen | Antagonist | Oui |
| Sitagliptin | Inhibitor | Oui |
| Finasteride | Inhibitor | Oui |
| Empagliflozin | Inhibitor | Oui |
| Metformin | Other | Oui |
| Montelukast | Other | — |